Solutions Pharmacy
Industry 06 · Online pharmacyPharmacy payment processing.
Acquiring banks experienced with NABP status, state pharmacy-board licensing and DEA registration. Pharmacy chargeback defense, auto-refill billing and multi-bank redundancy — for licensed online and compounding pharmacies processing $500K+ monthly.
Pharmacy-experienced banks
Countries supported
Status reviewed at onboarding
Continuity built in
Why pharmacy is different
Why pharmacies lose processing.
A regulatory mechanism unique to pharmacy — NABP listings flowing through card networks to acquirers — plus a layered licensing stack and endemic account instability make this one of the most processing-challenged verticals.
NABP "Not Recommended" — the primary termination trigger
The NABP maintains a "Not Recommended" site list that the card networks reference. When a pharmacy URL appears on it, networks flag it to acquiring banks, who are then required to terminate the account. This NABP → network → acquirer chain is the single most common reason online pharmacies lose processing — even legitimate, licensed pharmacies that are incorrectly listed.
NABP → network → terminateRegulatory stack — FDA, DEA, state boards
Pharmacy merchants face layered requirements acquirers must understand: DEA registration for controlled substances, state pharmacy-board licences per state served, and FDA registration for certain products — plus international equivalents abroad. Acquiring banks require documented licensing, not general healthcare experience, and mainstream processors don't have pharmacy-specialist underwriters.
Layered licensingHIPAA payment-data handling
HIPAA's Privacy and Security Rules apply to Protected Health Information, which can intersect with payment data when prescription details or patient identifiers appear in transaction records. Pharmacy merchants are responsible for HIPAA-applicable payment flows — and should work with acquiring banks and gateways experienced with them, and confirm obligations with compliance counsel.
PHI in payment dataAccount instability — pharmacy's endemic problem
Pharmacies face terminations other categories rarely see: AUP updates prompted by NABP actions, card-network compliance sweeps targeting pharmacy URLs, and chargeback spikes from shipping delays. Single-acquirer dependency is an existential risk — for pharmacy, multi-bank setup is a baseline operational requirement, not a premium feature.
Compliance-sweep riskHow MIDs solves it
Built for pharmacy compliance.
Acquiring banks that understand NABP and licensing, pharmacy chargeback defense, auto-refill billing and multi-bank continuity. See our chargeback-protection platform
Acquirers experienced in pharmacy compliance
We connect pharmacy merchants with acquiring banks whose underwriting teams understand NABP status, state pharmacy-board licensing, DEA registration and the specific documentation pharmacy onboarding requires. 30+ banks across 90+ countries — each with different expertise by sub-category (OTC, compounding, pet, subscription, international).
Healthcare-experienced · pharmacy-specialized banksPharmacy chargeback defense
Pharmacy chargebacks concentrate in two areas: "item not received" from shipping delays or customs holds, and "unauthorized transaction." The first needs carrier tracking, customs documentation and shipping-timeline disclosure; the second needs purchase-consent evidence and order logs. Pre-dispute alerts can resolve disputes before they count toward network thresholds.
Pre-dispute alerts · evidence packages · via integrated partnersSubscription medication & auto-refill billing
Chronic-condition auto-refill and subscription pharmacy programs need recurring billing with the same compliance considerations as other continuity merchants. "Forgot I subscribed" chargebacks require documented opt-in, clear cancellation and pre-renewal notification. We connect you with acquirers comfortable with subscription-medication models and the right dispute defense.
Recurring billing · auto-refill · pre-renewal noticesMulti-bank redundancy for account continuity
Given the NABP-driven and compliance-sweep termination mechanisms specific to pharmacy, single-acquirer dependency is an unacceptable risk. Simultaneous connections to multiple acquiring banks mean that if one responds to a network action by terminating pharmacy accounts, transactions route to backups without interruption — and for pharmacy, continuity directly affects patient access.
Multi-MID architecture · automatic routingFor pharmacy, continuity is patient access.
NABP listings and card-network compliance sweeps can terminate a pharmacy account with little warning. When that single account is your only one, dispensing stops. Multiple acquiring relationships keep medications flowing to patients through a termination at any one bank.
- Simultaneous connections to multiple acquiring banks
- A network action at one bank reroutes, never halts
- Backups kept approved in advance for fast cutover
- Continuity that protects patient access to medication
Account-stability models
A licensed online pharmacy survived an NABP-driven termination — without pausing dispensing.
The client
A licensed online pharmacy dispensing OTC and non-controlled prescription medications across multiple states, with an auto-refill program for chronic-condition patients and a growing international order base.
The problem
A card-network compliance sweep prompted by an NABP action led its single acquirer to terminate the account — halting dispensing overnight. Shipping-delay "item not received" disputes were also creeping up on international orders.
The approach
We documented the pharmacy's licensing and NABP standing for acquiring banks experienced in pharmacy, placed it across three acquirers in a Multi-MID architecture, and added carrier-tracking evidence plus pre-dispute alerts via integrated partners for the shipping-delay disputes.
The result
Dispensing resumed with zero patient-facing downtime, the chargeback ratio held below 0.5% with tracking-based representment, and the pharmacy now runs on three redundant acquirers — so a future network action at one never stops fulfillment.
Online pharmacy on the MATCH/TMF list? We specialize in recovery.
Pharmacies frequently appear on MATCH/TMF after terminations driven by NABP card-network actions, shipping-delay chargebacks or AUP updates. Most acquiring banks decline listed merchants automatically. With 25+ years of high-risk experience, MIDs maintains relationships with banks that evaluate pharmacy MATCH merchants case-by-case — if the termination was a compliance action rather than fraud or excessive chargebacks, evaluation on the merits is possible.
Who we serve
Every online-pharmacy model.
Online pharmacy (OTC & Rx)
Licensed pharmacies dispensing OTC and prescription medications. NABP status is the primary acquiring consideration, with state pharmacy-board licences required by state served and prescription verification handled by the merchant.
Licensed OTC & non-controlled Rx pharmacies
Telemedicine + pharmacy
Telehealth consultation plus dispensing creates multi-step payment flows — consultation fee, dispensing fee and medication cost, potentially through separate accounts. Needs acquirers experienced with the telehealth-to-pharmacy chain.
Consult-to-dispense telehealth platforms
Compounding pharmacy
Custom-formulation pharmacies under FDA 503B and state-by-state compounding rules — a compliance landscape unfamiliar to most acquirers. Requires specialist banks experienced in compounding pharmacy.
503B / state-compliant compounders
Subscription medications
Auto-refill programs for chronic conditions — the same ROSCA considerations as e-commerce continuity: documented opt-in, easy cancellation and clear billing disclosure.
Chronic-condition auto-refill programs
Running a continuity or subscription model? See our Subscription solutions
FAQ
Common pharmacy questions.
Banks decline pharmacies for several reasons: an NABP "Not Recommended" listing (card networks flag these to acquirers), lack of visible state pharmacy-board licensing, controlled-substance sales without DEA documentation, prohibited product categories, and chargeback patterns from medication shipping delays. Banks without pharmacy-experienced underwriting teams decline automatically rather than do the due diligence required.
The NABP (National Association of Boards of Pharmacy) maintains a "Not Recommended" site list of online pharmacies that don't meet its standards. The card networks reference it — when a pharmacy URL appears on the list, networks flag it to acquiring banks, who are then required to terminate the account. Legitimate pharmacies can be incorrectly listed. Pharmacy-experienced acquirers review NABP status as part of standard underwriting.
Controlled substances (Schedule II–V) require DEA registration, state controlled-substance licensing, and acquiring banks with explicit experience — which is extremely rare. Most pharmacy-experienced acquirers in our network work with OTC and non-controlled prescription medications. OTC has a lower compliance bar — some mainstream processors accept it if properly documented. Knowing where your product falls is the first question in pharmacy onboarding.
HIPAA's Privacy and Security Rules apply to Protected Health Information. Pharmacy payment processing can intersect with HIPAA when prescription details or patient identifiers appear in transaction records. Pharmacy merchants are responsible for ensuring their payment arrangements comply with HIPAA for their operations — a merchant obligation, not one processors fulfill on their behalf. We connect pharmacies with acquirers experienced in HIPAA-applicable flows; confirm specific obligations with compliance counsel.
International online pharmacy is one of the most processing-challenged categories. Pharmacies dispensing across borders face the most acquirer scrutiny, and legality varies significantly by jurisdiction. We work with acquiring banks that have explicit international-pharmacy experience and conduct jurisdiction-specific compliance reviews. Each international pharmacy is evaluated individually.
Pharmacies frequently appear on MATCH/TMF after terminations driven by NABP card-network actions, shipping-delay chargebacks or AUP updates. Most banks decline listed merchants automatically. With 25+ years of high-risk experience, MIDs maintains relationships with banks that evaluate pharmacy MATCH merchants case-by-case. If the termination was a compliance action rather than fraud or excessive chargebacks, evaluation on the merits is possible.
Want to go deeper? Read the High-Risk Merchant Account guide
Ready to process for your pharmacy?
Tell us your pharmacy type, licensing and the markets you serve. We'll advise on the acquiring structure, the chargeback defense and the multi-bank redundancy that keeps dispensing — and patient access — uninterrupted.